HOME >> MEDICINE >> NEWS
Early promise of simple test for diagnosing malignant hyperthermia

German authors of a research letter in this weeks issue of THE LANCET describe the potential of a straightforward test for identifying people at risk of the often fatal reaction to general anaesthetics, a syndrome known as malignant hyperthermia.

Malignant hyperthermia (MH) is a chain-reaction event triggered in susceptible individuals by commonly used general anesthetics. The signs of MH include a greatly increased body metabolism, muscle rigidity and eventual hyperthermia which may exceed 43 C. Death can result from heart attack, brain damage, internal hemorrhaging, or failure of other body systems.

Susceptibility to MH is diagnosed by muscle biopsy. A rapid and reliable test for MH would be beneficial to anaesthetists, as screening for mutations of the RYR1 gene detects only 20-40% of susceptible families. Martin Anetseder and colleagues from the University of Wrzburg, Germany, proposed that intramuscular injection of caffeine would increase local carbon dioxide pressure in individuals susceptible to MH.

After localised caffeine stimulation, carbon dioxide pressure was measured in the buttock muscle in 12 patients susceptible to MH, eight known not to be susceptible, and seven healthy individuals (the control group). Carbon dioxide pressure increased temporarily (to 63 mm Hg) in susceptible individuals compared with 44 mm Hg in non-susceptible participants, and 42 mm Hg in the control group.

Martin Anetseder comments: Despite these encouraging findings, large numbers in a multicentre trial are needed to define sensitivity and specificity before this test can allow a definite diagnosis of susceptibility to malignant hyperthermia.


'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
2-May-2002


Page: 1

Related medicine news :

1. Early onset of puberty the EU gets serious
2. Early HIV screening prolongs life and is affordable, Stanford study shows
3. Early supported discharge services can reduce long term dependency for stroke patients
4. Early surgical treatment not always necessary for patients with brain haemorrhage
5. Early seizures after epilepsy surgery predict more seizures
6. Early learning leaves lasting changes in brain, Stanford owl study shows
7. Early detection reduces threat of foot injury in college basketball players
8. Early results shed light on lung cancer screening advance
9. Early disclosure: Post-operative radiotherapy improves progression-free survival in prostate cancer
10. Early reports of thrombosis after insertion of drug-eluting stents
11. Early behavior problems linked with wheezing later in childhood

Post Your Comments:
(Date:5/22/2013)... that hospitals may be reaping enormous income for ... bloodstream infections contracted in their intensive care units. ... in the American Journal of Medical Quality ... who develops an avoidable central line-associated bloodstream infection ... for than a similar infection-free patient. Moreover, hospitals ...
(Date:5/22/2013)... 22, 2013 Recent tragedies including ... the school shooting in Newtown, Connecticut all resulted ... , Emergency medical practitioners train to respond ... Emergency Medical Services for Children (EMSC) Program specifically ... for the youngest patients. It is estimated 30 ...
(Date:5/22/2013)... 22, 2013 Space Girl Organics ... sponsor for this weekend's I Talk to Strangers Miracle ... am at Cocoa Riverside Park in Cocoa, FL. The event ... Talk to Strangers social movement. , As a sponsor, Space ... to participate in the event. Additionally, they are providing bananas ...
(Date:5/22/2013)... Pamela Isom, President and CEO of ICE ... 2013 Women of Influence Award in recognition for her ... reception took place on Thursday, May 2 at The ... particularly humbling for the 5,000 people ICE Safety Solutions ... to recognize the four to nine lives saved per ...
(Date:5/22/2013)... 2013 Homeopathic Vibes is implementing new store ... to the store during normal hours. On Wednesdays, they will ... to accommodate some of our patients who work shifts that ... or on Saturdays,” says owner and homeopathic consultant, Harminder Singh. ... 6 p.m. Monday through Friday; weekends are by appointment only. ...
Breaking Medicine News(10 mins):Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:Space Girl Organics to Sponsor May 25 Miracle Run/Walk 2Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2Health News:Homeopathic Vibes Now Open Late on Wednesdays 2
(Date:5/22/2013)... GROVE, Minn. , May 22, 2013 ... announced the successful completion of its global ... topiramate), an internally developed program for the ... company,s proprietary formulation technology.  USL255 is specifically ... reduce fluctuations in topiramate blood levels observed ...
(Date:5/22/2013)... , May 22, 2013  Generex Biotechnology Corporation ... demonstrating the superiority of the AE37 breast cancer vaccine ... ( www.antigenexpress.com ). The presentations will be made at ... Oncology (ASCO) to be held in Chicago ... The presentation entitled " Booster inoculations of ...
(Date:5/22/2013)...  Grifols, ein globales Unternehmen der Gesundheitsbranche ... , Spanien, präsentierte die Ergebnisse einer Studie, ... PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des Alpha1-Proteins ... Niveau anhebt, das innerhalb des für gesunde ... eine lebensbedrohliche, genetische Erkrankung, bei der der ...
Breaking Medicine Technology:Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4
Cached News: